Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Current Assets: 2011-2024

Historic Current Assets for Capricor Therapeutics (CAPR) over the last 14 years, with Dec 2024 value amounting to $163.4 million.

  • Capricor Therapeutics' Current Assets rose 17.63% to $101.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.0 million, marking a year-over-year increase of 17.63%. This contributed to the annual value of $163.4 million for FY2024, which is 221.27% up from last year.
  • According to the latest figures from FY2024, Capricor Therapeutics' Current Assets is $163.4 million, which was up 221.27% from $50.9 million recorded in FY2023.
  • Capricor Therapeutics' 5-year Current Assets high stood at $163.4 million for FY2024, and its period low was $33.7 million during FY2020.
  • Its 3-year average for Current Assets is $85.7 million, with a median of $50.9 million in 2023.
  • Data for Capricor Therapeutics' Current Assets shows a peak YoY soared of 221.27% (in 2024) over the last 5 years.
  • Capricor Therapeutics' Current Assets (Yearly) stood at $33.7 million in 2020, then increased by 8.20% to $36.4 million in 2021, then climbed by 17.71% to $42.9 million in 2022, then climbed by 18.58% to $50.9 million in 2023, then spiked by 221.27% to $163.4 million in 2024.